Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Shailaja Kale"'
Autor:
Shailaja Kale, Abd A Tahrani
Publikováno v:
Metabolism Open, Vol 10, Iss , Pp 100082- (2021)
Most guidelines and cardiovascular outcome trials (CVOTs) focus on secondary prevention of cardiovascular disease (CVD) in type 2 diabetes mellitus (T2DM). Patients with T2DM without established CVD (eCVD) also form a critical cohort, for whom primar
Externí odkaz:
https://doaj.org/article/e0193bc0dc584a129f6d5b662f24a4ab
Autor:
Ashok Kumar Das, Banshi Saboo, Rajeev Chawla, S. R. Aravind, Rajesh Rajput, Awadhesh K. Singh, J. J. Mukherjee, Ashok Jhingan, Parag Shah, Vaishali Deshmukh, Shailaja Kale, Shalini Jaggi, G. R. Sridhar, Rajnish Dhediya, Kumar Gaurav
Publikováno v:
International Journal of Diabetes in Developing Countries.
Autor:
Romik Ghosh, Pritesh R. Narvekar, Ghanshyam Goyal, Tirthankar Chaudhury, Manoj Chawla, Chirag Trivedi, Manoj Chadha, Debasis Basu, Shailaja Kale, Vaishali Deshmukh, Senthilnathan Mohanasundaram, Vaibhav Salvi, Shailesh Pitale, Sagarika Mukherjee, Arjun Nair, Santosh Ramakrishnan
Publikováno v:
Diabetes. 70
Real-world data on the effectiveness and safety of Gla-100 is limited in Indian people with T2DM. In a post-hoc analysis the effectiveness and hypoglycemia risk was studied in Indian T2DM participants (N=955) who started Gla-100 under daily routine p
Autor:
Ashish Suthar, Snehal Tanna, Purvi Chawla, Yogesh Kadam, Somesh Sharma, Aniruddha Tongaonkar, Sharat S Kolke, Atul B. Deshpande, Shrikant Deshpande, Shailaja Kale, Debjit Biswas, Vikas G. Pai
Publikováno v:
Journal of Diabetes Mellitus. :38-48
Context: Bitter melon (Momoradica charantia) is one of the well-known plants used for lowering blood glucose since antiquity. Aims: To compare the efficacy and safety of PDM011011 capsule (1200 mg/day) with Metformin (1000 mg/day) in a 15 weeks study
Autor:
Hemant Thacker, Jugal B Gupta, Ganapati Bantwal, Sakthivel Sivam, Sunil M Jain, Shailaja Kale, Sanjay Kalra, Banshi Saboo
Publikováno v:
North American Journal of Medical Sciences
Background: Diabetes is endemic with developing economies contributing to the bulk of this pandemic. Despite the evidence of incremental benefit of glycemic control starting early in life, acceptance of and adherence to modern medications remain subo
Autor:
Shailaja Kale
Publikováno v:
RSSDI Diabetes Update 2016
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::67aa30c597be02d30ff029ee837e772a
https://doi.org/10.5005/jp/books/13026_63
https://doi.org/10.5005/jp/books/13026_63
Publikováno v:
A Complete Textbook for GNM Internship
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e106df00c83817fc903f8035e8574142
https://doi.org/10.5005/jp/books/12602
https://doi.org/10.5005/jp/books/12602
Autor:
Firdos Ahmad, Debra Hoppensteadt, Sarfraz Ahmad, Shailaja Kale, Meganathan Kannan, Jawed Fareed, Renu Saxena
Publikováno v:
Blood Coagulation & Fibrinolysis. 16:487-490
Occurrence of heparin-induced thrombocytopenia (HIT) was investigated for 33 Indian patients undergoing cardiovascular surgery who received unfractionated heparin (UFH). Platelet counts were performed prior to the initiation of UFH therapy and 5-16 d
Publikováno v:
American Journal of Immunology. 1:55-59
We did the pilot study, in an attempt to determine the prevalence of HIT in Indians and determine its relationship, if any, to FcγRIIa polymorphism, the occurrence of heparin-induced thrombocytopenia (HIT) was investigated in 33 Indian patients unde
Autor:
Usha Kiran, Panangipalli Venugopal, Mittal D, Sandeep Chauhan, Neeraj Kumar, Shailaja Kale, Akshay Kumar Bisoi
Publikováno v:
Asian Cardiovascular and Thoracic Annals. 12:121-124
To compare different doses of tranexamic acid, 150 consecutive children with congenital cyanotic heart disease were randomly assigned to one of 5 groups of 30 each. Group A served as a control. Group B received 50 mg·kg−1 of tranexamic acid at ind